ka.haddad
TL2 Moderator · Dhaka
Contributes reviews on supplier material. Based in Dhaka.
Joined 10 May 2025 · last posted 7d
91 posts, newest first. Showing up to 150.
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #30 · Evidence › Preprints · 21 Jul 2026 · 5 likes What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report…
-
Submitting a sample: the process end to end Replied, post #96 · Sourcing › Independent verification · 20 Jul 2026 · 2 likes post #95 answers the question as asked. The question underneath it is different. Repeat testing: if you want to verify the same lot a second time, testing with a…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #93 · Compounds › Repair & healing peptides · 18 Jul 2026 · 25 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #61 · Practice › Dosing & titration · 13 Jul 2026 · 0 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #33 · Start Here › Welcome · 12 Jul 2026 · 1 like post #32 is right about the mechanism and I think understates the practical bit. The compound and evidence pages are updated regularly and they are worth reading when…
-
Prescription portability between countries Replied, post #95 · Access › International · 11 Jul 2026 · 18 likes Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when…
-
What to include when your question involves a chromatogram — one year on Replied, post #71 · Start Here › How to Ask · 10 Jul 2026 · 13 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #82 · Practice › Interactions · 10 Jul 2026 · 32 likes Picking up post #79: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #18 · Clinical › Comorbidities · 10 Jul 2026 · 1 like This follows post #15 rather than contradicting it. PCOS and metabolic overlap: polycystic ovary syndrome has metabolic overlap with obesity and insulin resistance.…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #8 · Access › Insurance & coverage · 7 Jul 2026 · 12 likes I read post #6 twice before replying, because I had assumed the opposite. Coverage for weight management versus diabetes: many formularies cover these compounds for…
-
Coming back to: Time to steady state after a dose increase Replied, post #89 · Pharmacology › Pharmacokinetics · 30 Jun 2026 · 0 likes Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and extends the half-life. Tirzepatide also has albumin binding…
-
CJC-1295 with and without DAC: what the modification does Replied, post #94 · Compounds › Secretagogues & GH axis · 25 Jun 2026 · 15 likes Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is plausible. They cannot show magnitude of effect in humans or…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #78 · Compounds › Repair & healing peptides · 24 Jun 2026 · 20 likes Stability of BPC-157 in solution: what has been measured in published work covers specific formulations under specific conditions. Extrapolating to a reconstituted…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #100 · Evidence › Journal club · 23 Jun 2026 · 3 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
A fridge failure and how I assessed the contents afterwards Replied, post #14 · Devices › Cold chain · 16 Jun 2026 · 0 likes I read post #12 twice before replying, because I had assumed the opposite. Assessing an excursion: if a package sat at room temperature for a time, visual inspection…
-
Asking a follow-up: new topic or new reply? Replied, post #8 · Start Here › How to Ask · 12 Jun 2026 · 18 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…
-
Sleep apnoea improving and the equipment implications Replied, post #4 · Wellbeing › Sleep · 8 Jun 2026 · 6 likes When sleep problems need attention: if sleep does not improve as weight loss continues or if it worsens, discussing with a clinician is prudent. Sleep disorders are…
-
A site rotation scheme that is easy enough to actually follow Replied, post #80 · Practice › Administration · 4 Jun 2026 · 12 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
-
Transporting a vial for a weekend away — a second dataset Replied, post #69 · Practice › Storage & stability · 1 Jun 2026 · 3 likes On post #65 — agreed on the reasoning, with one qualification. Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #57 · Safety › Contraindications · 31 May 2026 · 2 likes Concurrent insulin or sulfonylureas: not an absolute contraindication but requires dose adjustment and close monitoring for hypoglycemia. The combination is used with…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #66 · Practice › Storage & stability · 29 May 2026 · 7 likes I read post #64 twice before replying, because I had assumed the opposite. Container choice matters: the material of the vial, the rubber closure, the fill volume all…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #71 · Practice › Administration · 26 May 2026 · 25 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #35 · Compounds › Semaglutide · 22 May 2026 · 2 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Prescription requirements and telehealth models — a second dataset Replied, post #31 · Sourcing › Regulatory · 16 May 2026 · 1 like Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds with no human data are being used on theoretical grounds. The…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #116 · Devices › Syringes & needles · 13 May 2026 · 0 likes On post #112 — agreed on the reasoning, with one qualification. Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #114 · Practice › Storage & stability · 11 May 2026 · 5 likes I want to gently push back on the reply above about storage extrapolation. The advice is sound and the confidence is not. We are extrapolating from stability data on a…
-
Reading a trial's population section before its results Replied, post #12 · Evidence › Trials · 11 May 2026 · 8 likes post #11 answers the question as asked. The question underneath it is different. Dropout is information: high dropout rates can indicate tolerability problems or lower…
-
How much fluid is actually needed, and how you would know Started this topic · Nutrition & Training › Hydration & electrolytes · 1 May 2026 · 2 likes The question in the title: How much fluid is actually needed, and how you would know I will give what I have already checked below so nobody repeats it. Maintenance…
-
Coming back to: A structured critique template this community uses Replied, post #3 · Evidence › Study critique · 28 Apr 2026 · 3 likes Picking up post #2: that is the part I would want checked first. Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #39 · Evidence › Journal club · 25 Apr 2026 · 12 likes I read post #37 twice before replying, because I had assumed the opposite. Session format: read the paper before posting. The discussion is much better when everyone…
-
Whether an aggregate is worth publishing at all: a disputed topic — does this still hold? Replied, post #14 · Data & Tools › Datasets · 15 Apr 2026 · 2 likes Reproducibility: if sharing data, include enough context (compound, dose, timeframe, method) that someone reading it understands what it represents.
-
Follow-up: State-level differences that actually matter Replied, post #35 · Regional › North America · 5 Apr 2026 · 10 likes Regional variation in North America: access differs substantially by US state and Canadian province. Postcode is a major determinant of access.
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #21 · Meta › Announcements · 25 Mar 2026 · 0 likes post #20 answers the question as asked. The question underneath it is different. Feedback to announcements: if you have feedback on an announced change (not a question,…
-
Shoulders, tangent skims, and defensible integration — the long version Replied, post #17 · Analytics › HPLC & UHPLC · 20 Mar 2026 · 29 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
-
GLP-1 receptor distribution: central and peripheral Started this topic · Pharmacology › Receptor biology · 3 Feb 2026 · 7 likes Posting this under the heading it deserves: GLP-1 receptor distribution: central and peripheral Everything below is what sits behind that. A documentation question…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #53 · Meta › Site feedback · 25 Jan 2026 · 2 likes This follows post #50 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #38 · Practice › Storage & stability · 25 Jan 2026 · 0 likes post #37 is right about the mechanism and I think understates the practical bit. Beyond-use dating: the date after which a prepared solution should not be used. It is…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #78 · Practice › Side effects · 20 Jan 2026 · 22 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Aggregates and why a purity assay may miss them entirely Replied, post #66 · Analytics › Impurities & related substances · 11 Jan 2026 · 4 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #58 · Practice › Side effects · 9 Jan 2026 · 16 likes Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide information that "I have nausea" does not. Posting…
-
Realistic expectations for strength while losing weight quickly Replied, post #48 · Nutrition & Training › Resistance training · 27 Dec 2025 · 3 likes Post-weight-loss training: once weight loss is complete and energy deficit ends, training can shift to building again. The transition from preservation mode to building…
-
The decimal-point error, and the habit that catches it Replied, post #101 · Practice › Reconstitution · 18 Dec 2025 · 0 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Pen dose counters: what a click does and does not guarantee Replied, post #72 · Devices › Pens & autoinjectors · 17 Nov 2025 · 0 likes Pen confusion between compounds: if you are using multiple pens or alternating pens, confirming you have the correct pen before injection prevents administration…
-
EMA product information as a primary source Replied, post #27 · Regional › European Union · 3 Nov 2025 · 22 likes post #26 is right about the mechanism and I think understates the practical bit. Netherlands: CBG-MEB implements framework. GPs are first point of contact. Insurance…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #74 · Analytics › HPLC & UHPLC · 1 Nov 2025 · 4 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
A payment that went through twice: how it was resolved Replied, post #7 · Sourcing › Payments · 29 Oct 2025 · 20 likes Fraud and scams: if a supplier demands payment upfront with no recourse if delivery fails, you are taking a risk. Reputation and history of other buyers matter.
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #103 · Practice › Storage & stability · 25 Oct 2025 · 11 likes Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration. Light exposure is worth avoiding. The concentration matters…
-
Coverage in the US: a map of the usual obstacles Replied, post #4 · Regional › North America · 24 Oct 2025 · 28 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #58 · Start Here › Welcome · 18 Oct 2025 · 32 likes Worth separating two things that post #54 runs together. The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you…
-
Liver enzymes drifting down and what that usually means Replied, post #19 · Clinical › Bloodwork · 15 Oct 2025 · 17 likes Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually measurement noise, not a real change. Knowing the…
-
MHRA statements, read directly Replied, post #15 · Regional › UK & Ireland · 13 Oct 2025 · 9 likes Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable. That is not a front-line option but becomes relevant…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #46 · Compounds › Repair & healing peptides · 22 Sep 2025 · 15 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Payment method and the leverage it gives you, ranked Replied, post #27 · Sourcing › Payments · 17 Sep 2025 · 5 likes post #26 answers the question as asked. The question underneath it is different. Refund policy before ordering: ask what the policy is if you receive damaged material…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #40 · Analytics › Method validation · 9 Sep 2025 · 6 likes post #39 is right about the mechanism and I think understates the practical bit. Precision and repeatability: within-run and between-run variability of the method.…
-
Journal club: STEP-HFpEF and symptom endpoints Replied, post #10 · Evidence › Journal club · 3 Sep 2025 · 4 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #50 · Devices › Syringes & needles · 29 Aug 2025 · 0 likes post #49 is right about the mechanism and I think understates the practical bit. Sharps disposal: needles and syringes should be disposed in a sharps container (a…
-
Checking someone else's arithmetic: a worked example thread Replied, post #78 · Practice › Reconstitution · 16 Aug 2025 · 0 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
The storage lookup and where its data comes from Replied, post #9 · Data & Tools › Calculators · 13 Aug 2025 · 33 likes I read post #7 twice before replying, because I had assumed the opposite. Storage lookup: which conditions (temperature, time) are you considering storing in, and how…
-
Tracking that stops updating and then resumes Replied, post #17 · Sourcing › Logistics · 12 Aug 2025 · 9 likes At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at customs, it might be held or lost. Days of delay…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #32 · Compounds › Retatrutide · 2 Aug 2025 · 6 likes Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
-
Travel coolers and how long they really hold Replied, post #13 · Devices › Cold chain · 31 Jul 2025 · 14 likes Coming back to post #11, because the follow-up matters more than the original answer. Assessing an excursion: if a package sat at room temperature for a time, visual…
-
How to research a compound with no human data without deceiving yourself Replied, post #12 · Compounds › Other compounds · 30 Jul 2025 · 4 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
-
Which panel is worth repeating and which is worth ignoring Replied, post #71 · Clinical › Bloodwork · 28 Jul 2025 · 10 likes post #70 is right about the mechanism and I think understates the practical bit. HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #76 · Compounds › Repair & healing peptides · 28 Jul 2025 · 8 likes This follows post #73 rather than contradicting it. Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity confirmation by…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #7 · Compounds › Secretagogues & GH axis · 23 Jul 2025 · 12 likes Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is the only compound in this class with a registration-quality evidence base from a proper…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #31 · Compounds › Cagrilintide & amylin analogues · 9 Jul 2025 · 1 like Worth separating two things that post #27 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Repeatability versus intermediate precision Replied, post #99 · Analytics › Method validation · 30 Jun 2025 · 8 likes Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by running standards at multiple concentrations and…
-
Regression to the mean in progress reports Replied, post #24 · Research Methods › Statistics · 24 Jun 2025 · 0 likes Power and sample size: a study might be too small to detect a real effect (low power). Sample size calculations help determine how many participants are needed to…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #128 · Data & Tools › Calculators · 11 Jun 2025 · 8 likes Units: all calculators explicitly require units to be stated. This prevents the decimal-point errors that come from forgetting units. Always verify units in and out.
-
Pre-registering a personal experiment, seriously Replied, post #13 · Research Methods › N-of-1 designs · 26 May 2025 · 0 likes post #12 is right about the mechanism and I think understates the practical bit. Confounding in personal experiments: other things change when you start a medication…
-
An emergency department visit, described afterwards Replied, post #22 · Safety › Adverse events · 19 May 2025 · 14 likes post #21 answers the question as asked. The question underneath it is different. Allergic reactions: true allergy (anaphylaxis, severe rash) is rare with these peptide…
-
A well-designed study with a badly written abstract Replied, post #61 · Evidence › Study critique · 4 May 2025 · 8 likes Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #27 · Compounds › Retatrutide · 23 Apr 2025 · 0 likes On post #23 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #17 · Devices › Pens & autoinjectors · 12 Apr 2025 · 27 likes post #16 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Injection timing and sleep disruption — the long version Replied, post #3 · Wellbeing › Sleep · 12 Apr 2025 · 8 likes Apnoea monitoring: if you have diagnosed or suspected sleep apnoea, periodic monitoring (annually) during weight loss is prudent because severity changes.
-
Requesting a page: what makes a good request Replied, post #35 · Documentation › Wiki requests · 26 Mar 2025 · 0 likes This follows post #32 rather than contradicting it. Cross-referencing: if you notice two pages that should reference each other but do not, suggest the cross-reference.
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #50 · Clinical › Bloodwork · 9 Feb 2025 · 0 likes This follows post #47 rather than contradicting it. Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #60 · Analytics › COA interpretation · 26 Jan 2025 · 16 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #17 · Practice › Reconstitution · 2 Jan 2025 · 31 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #119 · Compounds › Tirzepatide · 30 Dec 2024 · 17 likes I read post #117 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #8 · Compounds › Secretagogues & GH axis · 29 Dec 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Started this topic · Compounds › Retatrutide · 24 Dec 2024 · 24 likes Second pass at: Triple agonism: additive, synergistic, or neither? — that is the question, and I have not found it answered plainly anywhere I have looked. I have seen…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Started this topic · Practice › Dosing & titration · 19 Dec 2024 · 2 likes On the subject in the title: Escalating every six weeks instead of four: what I observed over eight months — one year on Working notes rather than a conclusion. I have…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #12 · Data & Tools › Calculators · 6 Dec 2024 · 16 likes Coming back to post #10, because the follow-up matters more than the original answer. Offline use: all calculators are written in JavaScript and can be downloaded and…
-
Transporting a vial for a weekend away Replied, post #27 · Practice › Storage & stability · 3 Nov 2024 · 0 likes Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the…
-
Irish differences from the UK position Replied, post #63 · Regional › UK & Ireland · 28 Oct 2024 · 4 likes Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable. That is not a front-line option but becomes relevant…
-
Second pass at: Buffers, pH and why a formulation is a formulation Replied, post #17 · Pharmacology › Formulation chemistry · 25 Oct 2024 · 26 likes Picking up post #14: that is the part I would want checked first. Antioxidants: compounds that prevent oxidation (which damages peptides) are sometimes included.…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #26 · Compounds › Semaglutide · 15 Oct 2024 · 26 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #79 · Practice › Dosing & titration · 8 Oct 2024 · 0 likes Picking up post #76: that is the part I would want checked first. How the published trials escalated: they used specific step sizes and intervals. The STEP programme…
-
Guidelines revision: what changed and why Replied, post #125 · Meta › Announcements · 28 Jul 2024 · 20 likes RSS: if you prefer to receive announcements by feed rather than visiting the site, RSS is available for this subcategory.
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #108 · Compounds › Retatrutide · 23 Jul 2024 · 11 likes Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step sizes are documented and they may or may not…